Malaria: treatment.

It all started in 1999, when we launched the first fixed-dose artemisinin-based combination therapy (ACT), a new class of malaria treatment. ACTs have since become a standard of care for millions of patients around the world. Our ACT is approved in more than 60 countries, and is currently the only ACT approved by the US Food and Drug Administration. Over the past three years, on average, a treatment was made available to approximately 200,000 malaria patients every day.